CLIO Cosmetics co., Ltd

As of June 30, 2026, CLIO Cosmetics co., Ltd carries a market capitalization of 168.24B, placing it among publicly traded companies globally. Its enterprise value stands at 10.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CLIO Cosmetics co., Ltd's next confirmed earnings release is scheduled for November 12, 2026.

As of June 30, 2026, CLIO Cosmetics co., Ltd has 17.52M shares outstanding.

As of June 30, 2026, CLIO Cosmetics co., Ltd trades at a trailing price-to-earnings ratio of 5.71. The price-to-sales ratio is 0.51, and the price-to-book ratio stands at 0.65.

As of June 30, 2026, CLIO Cosmetics co., Ltd trades at an EV/EBITDA multiple of 0.33 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 0.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. CLIO Cosmetics co., Ltd trades at an EV/FCF ratio of 0.30, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 10.65B versus a market cap of 168.24B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, CLIO Cosmetics co., Ltd maintains a current ratio of 4.05, meaning it holds 4.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.37, indicating elevated leverage, while an interest coverage ratio of 237.15 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, CLIO Cosmetics co., Ltd posted a return on equity (ROE) of 11.93, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.29 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.30, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.95, useful for judging operating efficiency across full business cycles. The company generates approximately 905.47M in revenue per employee across its workforce of 364.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.88 indicates how many times CLIO Cosmetics co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, CLIO Cosmetics co., Ltd recorded 7.49B in income tax expense. That works out to an effective tax rate of 20.50, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 36.56B, leaving 29.45B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, CLIO Cosmetics co., Ltd's stock has declined approximately 26.38% over the past 52 weeks. The 50-day moving average sits at 12,192.00, while the 200-day moving average is 11,967.35.

Over the twelve months ended June 30, 2026, CLIO Cosmetics co., Ltd generated 329.59B in revenue and converted that into 29.45B in net income, yielding earnings per share of 1,658.53. EBITDA reached 31.90B, while operating income came in at 29.18B.

As of June 30, 2026, CLIO Cosmetics co., Ltd holds 163.95B in cash and equivalents against 8.67B in total debt, resulting in a net debt position of -118.23B. Total book value stands at 259.75B, with working capital of 167.35B providing operational flexibility.

CLIO Cosmetics co., Ltd produced 36.33B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -459.99M in capital expenditures, free cash flow totaled 35.87B - equivalent to 2,047.11 per share.

Over the twelve months ended June 30, 2026, CLIO Cosmetics co., Ltd posted a gross margin of 50.34, reflecting its pricing power and cost economics. The operating margin of 8.85 and net profit margin of 8.94 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, CLIO Cosmetics co., Ltd paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 21.32, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.32, meaning CLIO Cosmetics co., Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, CLIO Cosmetics co., Ltd has an Altman Z-Score of 3.91, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.